World Federation of Hemophilia
Jun 3, 2025, 08:58
World Federation of Hemophilia (WFH) 2024 Annual Report: Major Advances in Global Care and Access for Bleeding Disorders
The World Federation of Hemophilia (WFH) just posted on X:
“In 2024, the WFH: Increased WGBD identification and diagnosis, enrolled 1st patient in the GeneTherapy Registry and advocated for WHO Essential Medicines updates and more!”
In 2024, the World Federation of Hemophilia (WFH) made remarkable progress in advancing global care and access. These achievements mark a strong step forward in improving lives for people with bleeding disorders around the world.
You can read 2024 WFH Annual Report for more information!
Stay informed with the latest updates in bleeding disorders—read Hemostasis Today.
-
Jul 13, 2026, 11:25Luisa Müller: Advancing Anticoagulation Strategies for VITT at ISTH 2026
-
Jul 13, 2026, 10:49Joshua Zeidner: Advancing Menin Inhibitor Therapy in MD Education AML-ALL US Focus 2026
-
Jul 13, 2026, 10:25Flora Peyvandi: A Practical Approach to ALT Elevation After Gene Therapy at ISTH 2026
-
Jul 13, 2026, 10:02Jessica Garcia: Where Science and Community Come Together at ISTH 2026
-
Jul 13, 2026, 09:46Fabrice Cognasse: Is There Such a Thing as the Perfect Platelet Product?
-
Jul 13, 2026, 09:42Cancer-Associated Arterial Thromboembolism: Redefining the Thrombotic Burden in Oncology
-
Jul 13, 2026, 05:59Connecting and Collaborating at ISTH 2026 – NNHF
-
Jul 13, 2026, 05:58Lara Monica: Back at ISTH – Looking Forward to Science and Reconnections!
-
Jul 13, 2026, 05:57Barbara Adams Krolak: Exciting Updates From the ISTH 2026 Regulatory Session